Health Care & Life Sciences » Pharmaceuticals | DelMar Pharmaceuticals Inc.

DelMar Pharmaceuticals Inc. | Ownership

Companies that own DelMar Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Franklin Advisers, Inc.
804,000
3.65%
-272,923
0%
06/30/2018
Virtu Financial BD LLC
43,229
0.2%
5,544
0%
06/30/2018
KMS Financial Services, Inc.
40,000
0.18%
0
0%
06/30/2018
Citadel Advisors LLC
22,260
0.1%
6,925
0%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
13,000
0.06%
-571
0%
06/30/2018
Raymond James Financial Services Advisors, Inc.
12,500
0.06%
0
0%
06/30/2018
Vantage Investment Advisors LLC
10,000
0.05%
0
0%
06/30/2018
UBS Securities LLC
9,646
0.04%
-7,614
0%
06/30/2018
TrustCore Financial Services LLC
5,000
0.02%
0
0%
06/30/2018
BMO Asset Management Corp.
4,262
0.02%
0
0%
06/30/2018

About DelMar Pharmaceuticals

View Profile
Address
999 West Broadway
Vancouver British Columbia V5Z 1K5
Canada
Employees -
Website http://www.delmarpharma.com
Updated 07/08/2019
DelMar Pharmaceuticals, Inc. is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. It offers VAL-083; drug discovery research; as well as patents and intellectual property. The company was founded by Jeffrey A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.